CN Stock MarketDetailed Quotes
688488 Jiangsu Aidea Pharmaceutical
- 7.90
- +0.41+5.47%
Market Closed Sep 27 15:00 CST
3.32BMarket Cap-29699P/E (TTM)
7.99High7.56Low38.35KlotVolume7.56Open7.49Pre Close29.69MTurnover0.91%Turnover RatioLossP/E (Static)420.78MShares17.4052wk High3.07P/B3.32BFloat Cap6.5852wk Low8.99Limit Up420.78MShs Float45.21Historical High5.99Limit Down5.74%Amplitude6.58Historical Low--Dividend TTM7.74Avg Price17.05KlotAsk--Div YieldTTM100Lot Size19.97KlotBid
Jiangsu Aidea Pharmaceutical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 10.99%190.13M | 12.39%70.06M | 46.33%368.58M | 100.31%291.83M | 58.76%171.3M | 2.11%62.34M | -19.26%251.89M | -40.47%145.69M | -27.50%107.9M | -31.90%61.05M |
| Refunds of taxes and levies | -98.00%35.15K | --35.31K | -68.77%4.37M | -56.41%4.25M | -72.96%1.76M | ---- | 245.17%13.98M | 198.70%9.74M | 185.79%6.5M | ---- |
| Cash received relating to other operating activities | -38.42%3.01M | -50.69%2.57M | -64.49%18.89M | -75.70%11.89M | -78.50%4.89M | -76.49%5.21M | 63.32%53.21M | 390.71%48.93M | 226.26%22.74M | 370.31%22.17M |
| Cash inflows from operating activities | 8.55%193.17M | 7.58%72.67M | 22.80%391.85M | 50.70%307.97M | 29.75%177.95M | -18.82%67.55M | -8.47%319.08M | -20.78%204.37M | -13.24%137.15M | -11.81%83.21M |
| Goods services cash paid | -14.97%126.59M | 30.79%71.03M | 35.91%267.38M | 63.46%209.51M | 57.28%148.88M | -7.67%54.31M | -8.15%196.74M | -30.42%128.17M | -28.30%94.66M | 5.52%58.82M |
| Staff behalf paid | -1.45%64.27M | 1.66%36M | 34.10%123.71M | 33.75%88.25M | 39.99%65.22M | 40.18%35.41M | 43.09%92.25M | 38.97%65.98M | 38.28%46.59M | 35.17%25.26M |
| All taxes paid | -54.14%6.6M | 131.73%5.17M | 264.41%26.65M | 597.57%19.49M | 832.04%14.4M | 151.05%2.23M | -53.44%7.31M | -81.44%2.79M | -88.09%1.55M | -88.63%889.24K |
| Cash paid relating to other operating activities | 7.98%74.07M | -3.85%30.78M | 21.67%140.33M | 5.85%100.37M | 14.97%68.6M | 34.01%32.02M | 73.15%115.33M | 124.70%94.82M | 129.07%59.67M | 151.08%23.89M |
| Cash outflows from operating activities | -8.60%271.54M | 15.34%142.99M | 35.57%558.07M | 43.14%417.62M | 46.74%297.1M | 13.87%123.97M | 14.03%411.64M | 0.98%291.77M | -1.11%202.46M | 18.63%108.86M |
| Net cash flows from operating activities | 34.23%-78.36M | -24.63%-70.32M | -79.60%-166.22M | -25.46%-109.65M | -82.42%-119.15M | -119.94%-56.42M | -648.15%-92.55M | -182.36%-87.4M | -40.02%-65.31M | -1,094.44%-25.65M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | --879.44K | --879.44K | --879.44K | ---- | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | -36.52%3.02M | -50.38%1.54M | -13.90%7.44M | 15.80%6.81M | 1.17%4.76M | 135.64%3.11M | -39.02%8.64M | -47.30%5.88M | -37.07%4.7M | -68.43%1.32M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | 93.44%1.32M | -95.45%1.39M | -99.60%124.05K | -99.59%123.75K | 6,731.20%683.12K | --30.68M | --30.68M | --30M |
| Cash received relating to other investing activities | -29.97%470.01M | -41.66%245.01M | 18.06%1.11B | 31.45%935M | 20.72%671.2M | 174.10%420M | -49.32%936M | -50.87%711.29M | -44.03%556M | -72.89%153.23M |
| Cash inflows from investing activities | -30.12%473.03M | -41.75%246.55M | 17.91%1.11B | 26.24%944.09M | 14.47%676.96M | 129.33%423.24M | -49.21%945.33M | -48.74%747.85M | -40.91%591.38M | -67.59%184.55M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -28.13%32.99M | 18.88%25.52M | -49.25%71.2M | -49.94%52.71M | -46.90%45.91M | -58.73%21.47M | 48.02%140.3M | 61.86%105.29M | 60.02%86.45M | 187.84%52.03M |
| Cash paid to acquire investments | --650.53K | ---- | ---- | ---- | ---- | ---- | 44.14%87.75M | 44.14%87.75M | ---- | ---- |
| Cash paid relating to other investing activities | -26.75%370.02M | -41.69%175M | -13.62%970M | -5.91%765.22M | -7.82%505.12M | -12.56%300.12M | -23.86%1.12B | -30.02%813.32M | -21.17%548M | -31.77%343.22M |
| Cash outflows from investing activities | -26.74%403.66M | -37.65%200.52M | -22.93%1.04B | -18.72%817.93M | -13.15%551.03M | -18.64%321.59M | -17.15%1.35B | -21.87%1.01B | -21.57%634.45M | -31.57%395.25M |
| Net cash flows from investing activities | -44.92%69.37M | -54.72%46.03M | 118.10%73.44M | 148.80%126.16M | 392.44%125.94M | 148.24%101.65M | -276.00%-405.72M | -251.39%-258.51M | -122.44%-43.06M | -2,489.35%-210.69M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | --5.48M | --5.48M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -23.08%200.3M | 167.75%140.3M | 92.82%395.29M | 87.12%299.39M | 80.83%260.4M | 4.80%52.4M | --205M | --160M | --144M | --50M |
| Cash inflows from financing activities | -23.08%200.3M | 167.75%140.3M | 95.50%400.77M | 90.54%304.87M | 80.83%260.4M | 4.80%52.4M | --205M | --160M | --144M | --50M |
| Borrowing repayment | 110.35%210.35M | 213.44%100.3M | --195M | --109M | --100M | --32M | ---- | ---- | ---- | ---- |
| Dividend interest payment | 57.93%7.3M | 87.38%3.61M | 236.37%11.66M | 302.73%7.92M | 726.03%4.62M | --1.92M | -82.81%3.47M | -90.25%1.97M | -97.22%559.76K | ---- |
| Cash payments relating to other financing activities | -18.81%1.29M | -8.21%539.52K | -39.39%3.33M | -51.16%2.43M | -50.03%1.59M | -62.19%587.77K | 99.10%5.5M | 117.94%4.97M | 101.18%3.18M | --1.55M |
| Cash outflows from financing activities | 106.13%218.94M | 202.64%104.44M | 2,242.27%209.99M | 1,621.39%119.34M | 2,736.57%106.22M | 2,119.92%34.51M | -60.89%8.97M | -69.10%6.93M | -82.78%3.74M | --1.55M |
| Net cash flows from financing activities | -112.09%-18.64M | 100.44%35.86M | -2.68%190.78M | 21.21%185.53M | 9.93%154.18M | -63.08%17.89M | 955.21%196.03M | 782.15%153.07M | 745.06%140.26M | --48.45M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 140.49%32.82K | 103.45%9.37K | -99.69%1.43K | -112.80%-78.85K | -126.03%-81.06K | -670.39%-271.52K | 409.73%467.68K | 1,011.69%616.26K | 461.50%311.41K | -339.28%-35.24K |
| Net increase in cash and cash equivalents | -117.16%-27.61M | -81.58%11.57M | 132.47%98M | 205.06%201.96M | 399.85%160.89M | 133.44%62.84M | -254.69%-301.77M | -263.87%-192.22M | -73.92%32.19M | -3,290.83%-187.94M |
| Add:Begin period cash and cash equivalents | 79.16%221.8M | 79.16%221.8M | -70.91%123.8M | -70.91%123.8M | -70.91%123.8M | -70.91%123.8M | 84.64%425.58M | 84.64%425.58M | 84.64%425.58M | 84.64%425.58M |
| End period cash equivalent | -31.79%194.2M | 25.04%233.37M | 79.16%221.8M | 39.60%325.76M | -37.81%284.7M | -21.46%186.64M | -70.91%123.8M | -32.90%233.35M | 29.35%457.77M | 5.64%237.64M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Notarized Tianye Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Shing Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data